Accuray Inc.

Wayne Wu has served as a member of Accuray’s board of directors since April 1998 and Chairman since May 2004. Mr. Wu is also a member of Green Tree Investment Company board of directors. Green Tree Investment Company owns and operates a chain of upscale budget business hotel in the People’s Republic of China. Since June 2005 Mr. Wu has been the President of Pacific Health Investment, Inc., a life science investment company. Prior to Pacific Health Investment, Inc, Mr. Wu co-founded Pacific Republic Capital Group in February 1998, a venture capital fund that specialized in real estate and life sciences investment. From February 1998 through May 2005 Mr. Wu was the fund’s co-manager and held various board seats in companies which Pacific Republic Capital Group had made an investment including Accuray Incorporated, Aurora Imaging Technology, Inc. and Sandpoint Design, Inc. Prior to founding Pacific Republic Capital Group Mr. Wu was the Assistant to the Chairman & CEO of Preferred Bank from August 1997 to February 1998, and a senior loan officer of Sumitomo Trust and Banking Corporation from December 1995 to August 1997. Mr. Wu graduated from National Central University in Taiwan with a Bachelor of Science Degree in Mathematics and received his Masters Degree in Mathematics from University of Southern California.

Derek Bertocci has served as chief financial officer for Accuray since January 2009. Prior to joining Accuray, Bertocci served as chief financial officer and secretary for BioForm Medical Incorporated, a medical aesthetics company. Prior to this, Bertocci was chief financial officer of Laserscope, a provider of lasers and fiber optic devices for urology and aesthetic surgery. Earlier in his career, Bertocci held several positions, including chief financial officer, at VISX, a leading provider of systems used in laser vision correction surgery. Bertocci earned his Certified Public Accountant (CPA) certification while working for PricewaterhouseCoopers. Bertocci earned a bachelor’s degree from Stanford University and a master’s degree in business administration from the University of Southern California.

Eric P. Lindquist has served as our Senior Vice President, Chief Marketing Officer since November 2004. From March 2004 to November 2004, Mr. Lindquist served as Senior Vice President of Marketing at Omnicell, Inc., a healthcare services company. From March 1997 to March 2004, Mr. Lindquist served in various senior management roles, including Presi...

Wade B. Hampton served as our Senior Vice President, Worldwide Sales from August 2006 through April 2007, at which time he became Senior Vice President, CSO. From March 2003 to August 2006, Mr. Hampton served in various senior management roles, including Senior Vice President, Americas at Lumenis Ltd., a medical device company. From October 2001 to March 2003, he served as Vice President of International at Natus Medical, Inc., a medical device company. From September 1999 to October 2001 he served as Vice President of International at Coherent, Inc., a medical device company. From January 1997 to September 1999, he served in various positions, including President and Vice President, at Andros Incorporated, a scientific instrumentation company. Mr. Hampton holds a B.A. in Business Administration from the University of Florida.

Mr. Weiss has served as our President since March 2008 and as our Chief Executive Officer since November 2007. He also served as President of CooperVision, our contact lens subsidiary from March 2007 to February 2008. He previously served as our Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as our Chief Financial Officer from September 1989 to January 2005. He also served as our Treasurer from 1989 to March 2002. Since joining us in 1977, he has held a number of finance positions both with us and Cooper Laboratories, Inc. (our former parent). Mr. Weiss is also a director of Accuray Incorporated, a company that develops and markets a sophisticated robotic radiosurgery system designed to treat tumors, and serves on its Nominating Committee and as Chair of its Audit Committee.

Dr. Berndt Wowra received his degree from the University of Tuebingen in 1981 and completed his fellowship at the Brain Research Institute, University of Tuebingen. He has been trained in Neurosurgery, Sterotactic Neurosurgery and Radiosurgery and in 1990 he received his board of certification as a neurosurgeon. From 1992- 2005, Dr. Wowra served as the medical director of the Gamma Knife Center Munich, and from 2003- 2004 he served as the medical director of the Gamma Knife Center Frankfurt. Currently, Dr. Wowra is the co-director of the European CyberKnife® Center, Munich along with Alexander Muacevic, M.D., Ph.D.

Dr. Lee has received three degrees in Nuclear Engineering, including his Ph.D. from the Massachusetts Institute of Technology where he worked to develop novel radiation sources for neutron capture therapy of glioblastomas. After post-doctoral work at Los Alamos National Laboratory and the Department of Radiation Oncology at the University of Maryland, he became the lead physicist for the new CyberKnife facility at Sinai Hospital in Baltimore, MD. After more than three years and 650 patients at Sinai, he accepted a position at the San Diego CyberKnife Center as their lead CyberKnife physicist in 2006. Dr. Lee is certified in Therapeutic Radiology Physics by the American Board of Radiology and serves on the American Association of Physicists in Medicine's Task Group 135 (QA for Robotic Radiosurgery). He is a contributing author to the book Robotic Radiosurgery Vol. 2 in the area of abdominal radiosugery treatment planning, and he chairs the Accuray physics focus group for treatment planning and optimization.

Dr. Gibbs is an Assistant Professor of Radiation Oncology at the Stanford Cancer Center. Dr. Gibbs earned her MD from Stanford University. After completing her residency in Radiation Oncology at Stanford University, she joined the faculty at Stanford. She specializes in central nervous system tumors in adults and children. Dr. Gibbs is the Co-Director of the Cyberknife Radiosurgery Program at Stanford. She recently received the prestigious, Best Doctors of America Award for 2005-2006.

Professor Fraser C. Henderson, Sr., is Director of Neurosurgery of the Spine and Craniocervical Junction, Co-Director of the Neuro-Oncology and Childhood Cancer Division of the Lombardi Comprehensive Cancer Center, Co-Director of Radiosurgery and Medical Director of the Acute and Step-Down Brain and Spine Units at Georgetown University Hospital.. He specializes in tumors of the skull base, spinal cord and spine, and has worked with the CyberKnife System to advance stereotactic radiosurgical treatment of spinal and craniocervical tumors. He is a well- known lecturer on treatment of the disorders of the spine having made over 70 scientific presentations and published 50 articles in professional journals and specialty texts. He holds 4 patents in the US for devices pertaining to cancer and trauma of the spine. His present research focuses on regulation of surface molecules in cancer and trauma, and the development of stress models of the brainstem and spine in chronic and acute injury. Dr. Henderson received his baccalaureate and medical degree from the University of Virginia. He, received training in general surgery at the Naval Regional Medical Center in Portsmouth, Virginia, and then studied neurosurgery under Professor Phanor Perot at the Medical University of South Carolina. Commander Henderson served in three campaigns with the USN. He was the International Fellow for Spine and Craniocervical Surgery under Professor Crockard, at The National Hospitals for Neurology and Neurosurgery at Queen Square, London. Dr. Henderson holds membership in the Cushing Society, the American Association of Neurological Surgeons, the Washington Academy of Neurosurgeons, the Joint AANS-CNS Sections for Tumors, Spine and Peripheral Nerves, Trauma and Critical Care.

Founder and CEO, the Urschel Recovery Science Institute Chief of Medical Strategy, EnterHealth Global LLC. Dr. Harold C. Urschel, III is CEO /Founder of the Urschel Recovery Science Institute in Dallas, Texas. Dr. Urschel graduated from Princeton University, U.T. Southwestern Medical School, and The University of Pennsylvania for his undergraduate and medical training. Dr. Urschel also graduated from Stanford University Graduate School of Business with a Masters Management Administration. Dr. Urschel is currently board certified in both addiction and general psychiatry. The primary goal of Dr. Urschel's Recovery Science institute as well as his addiction treatment internet site (www.EnterHealth.com) is to combine the best behavioral treatment methods with the latest scientifically proven medications to maximize his patients' chances of a successful recovery from the life threatening, chronic medical disease of addiction.

Prof. Levendag completed medical training in the St. Elisabeth Hospital, Curaçao, Dutch West Indies and the Medical School in Utrecht; he graduated from Utrecht University, The Netherlands Prof. Levendag's post-graduate medical training included the completion of an internship in general surgery at Canisius Hospital, Nijmegen, The Netherlands. His post-graduate medical specialty training included ENT surgery training at Sint Radboud University Hospital, Nijmegen, The Netherlands. After being board certified as an ENT Surgeon, he completed his medical education with advanced Radiation Oncology training at the Radboud University Hospital, the Groningen University Hospital, Groningen, The Netherlands and Memorial Sloan Kettering Cancer Centre, New York, USA. In 1981 he defended his thesis on “The Inner Ear and Hyperbaric Conditions”. In 1984/1985 he was awarded the Anna Hamann Scholarship in Radiation Oncology, allowing him to be trained in the MSKCC in New York. Since January 1987, Prof. Levendag has been the chairman of the Radiation Oncology Department at the Daniel Den Hoed Cancer Centre, Rotterdam, and the chairman of the Radiation Oncology Department at Rotterdam-Dijkzigt University Hospital, Rotterdam, The Netherlands. Both institutions have merged since 1995 into the Erasmus Medical Center. Prof. Levendag utilizes advanced technologies including brachytherapy and the CyberKnife Robotic Radiosurgery System and is a respected expert in the treatment of Head and Neck cancer.

Roderick (Rod) Young is an experienced medical industry executive, having served as President and CEO of five medical companies since 1987. A mix of both medical device and pharmaceutical endeavors, these companies include Diasonics, Toshiba America MRI, Focus Surgery, General Surgical Innovations, Vivant Medical, and Targesome, Inc.